Price
$227.69
Increased by +0.63%
Dollar volume (20D)
297.50 M
ADR%
1.74
Earnings report date
Jan 29, 2025
Shares float
175.47 M
Shares short
10.11 M [5.76%]
Shares outstanding
193.28 M
Market cap
43.73 B
Beta
0.44
Price/earnings
30.05
20D range
224.39 253.27
50D range
221.45 253.27
200D range
213.82 253.27

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally.

The company'sU. S.

Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers.

This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics.

Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry.

The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023.

Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.

  • Quarterly earnings
  • Annual earnings
Reported date EPSChange YoY EstimateSurprise
Nov 6, 24 3.34
Increased by +16.78%
3.22
Increased by +3.73%
Jul 31, 24 3.34
Increased by +14.38%
3.22
Increased by +3.73%
May 1, 24 3.80
Increased by +8.57%
3.69
Increased by +2.98%
Jan 31, 24 3.28
Increased by +21.03%
2.89
Increased by +13.49%
Nov 2, 23 2.86
Increased by +10.00%
2.80
Increased by +2.14%
Aug 2, 23 2.92
Increased by +11.45%
2.82
Increased by +3.55%
May 2, 23 3.50
Increased by +8.70%
3.30
Increased by +6.06%
Feb 1, 23 2.71
Increased by +5.04%
2.62
Increased by +3.44%
  • Quarterly financials
  • Annual financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Sep 30, 24 79.05 B
Increased by +14.69%
3.38 M
Decreased by -99.04%
Increased by +0.00%
Decreased by -99.16%
Jun 30, 24 74.24 B
Increased by +10.90%
483.46 M
Increased by +0.81%
Increased by +0.65%
Decreased by -9.10%
Mar 31, 24 68.41 B
Increased by +7.81%
420.77 M
Decreased by -3.36%
Increased by +0.62%
Decreased by -10.36%
Dec 31, 23 72.25 B
Increased by +14.97%
601.50 M
Increased by +25.38%
Increased by +0.83%
Increased by +9.06%
Sep 30, 23 68.92 B
Increased by +12.67%
350.56 M
Increased by +18.94%
Increased by +0.51%
Increased by +5.57%
Jun 30, 23 66.95 B
Increased by +11.46%
479.58 M
Increased by +17.84%
Increased by +0.72%
Increased by +5.73%
Mar 31, 23 63.46 B
Increased by +9.94%
435.40 M
Decreased by -20.55%
Increased by +0.69%
Decreased by -27.73%
Dec 31, 22 62.85 B
Increased by +5.40%
479.75 M
Increased by +6.82%
Increased by +0.76%
Increased by +1.35%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY